← All stories
Markets
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
Rocket Lab posted record Q2 revenue and backlog and keeps winning defense contracts, but shares remain volatile as investors await Neutron's fourth-quarter debut before re-rating the stock.
Covered by 1 outlet
All coverage · 1 article